European Union BSE cosmetics tallow exemption expected by March -- COLIPA conference.
This article was originally published in The Rose Sheet
Executive Summary
EUROPEAN UNION BSE TALLOW EXEMPTION FOR COSMETICS ANTICIPATED IN MARCH when the European Commission is expected to decide on the proposal granting a derogation for tallow derivatives used in cosmetics and pharmaceuticals from the Jan. 1 European Union ban on the use of all transmissible spongiform encephalopathies (TSEs) specified risk materials (SRMs), according to the Commission's Directorate General III Pharmaceutical and Cosmetics Unit. Speaking at the European Cosmetic, Toiletry and Perfumery Association (COLIPA) Information Day in Brussels Feb. 4, DG III Administrator Lee Bansil said the exemption, which would be presented to the Commission "in the coming days," would carve out tallow from the ban when processed using appropriate methods designated by the Scientific Committee on Cosmetic Products and Non-Food Products (SCCNFP).